EMGRAST M 500MCG INJECTION

EMGRAST M 500MCG INJECTION belongs to the class of medications called colony-stimulating factors used to treat neutropenia, a deficiency of specific white blood cells caused by cancer, bone marrow transplant, chemotherapy, or other diseases. EMGRAST M 500MCG INJECTION helps reduce the chance of infection in cancer patients and those receiving chemotherapy medicines. Neutropenia is a condition in which the quantity of neutrophils (white blood cells) in the blood is reduced.

EMGRAST M 500MCG INJECTION contains Sargramostim, a growth factor that stimulates the formation of white blood cells and helps reduce the chances of infection in cancer patients receiving chemotherapy.

A healthcare professional will administer EMGRAST M 500MCG INJECTION. Sometimes, you may experience injection site responses such as pain, redness, or swelling. You may also experience nausea, vomiting, headache, diarrhoea, stomach pain, mouth sores, loss of appetite, hair loss and bone, joint, or muscle pain. Most of these side effects do not necessitate medical treatment and will gradually fade over time. However, if you suffer these side effects regularly, you should consult your doctor.

It is not suggested to use EMGRAST M 500MCG INJECTION in those who have had severe allergic responses, including anaphylaxis, to human granulocyte-macrophage colony-stimulating factor, yeast-derived products, or any component of EMGRAST M 500MCG INJECTION. To rule out any negative effects, keep your doctor informed about your medical condition and all medications you take. Inform your doctor if you are pregnant, intend to become pregnant, or are currently breastfeeding. Contact your doctor if you become pregnant while using EMGRAST M 500MCG INJECTION.

EMGRAST M 500MCG INJECTION contains 'Sargramostim,' which is a growth factor. It belongs to the cytokine family of proteins and is extremely similar to a natural protein (granulocyte-colony stimulating factor) produced by the body. EMGRAST M 500MCG INJECTION acts by encouraging the bone marrow to generate more white blood cells, aiding infection resistance. EMGRAST M 500MCG INJECTION is used to boost white blood cell count following cancer treatment or chemotherapy, bone marrow transplantation, severe persistent neutropenia, neutropenia in HIV patients, and before stem cell donation.

• Injection site reactions
• Nausea
• Asthenia abnormal weakness
• Anorexia (loss of appetite)
• laboratory abnormalities
• stomatitis (painful swelling and sores inside the mouth)
• Vomiting
• Headache
• Diarrhea
• Stomach pain
• Mouth sores
• Loss of appetite
• Hair loss
• Bone, joint, or muscle pain

Extreme caution and special care should be taken while using EMGRAST M 500MCG INJECTION in patients with heart disorders, liver or renal dysfunction, leukocytosis (elevated white blood cell count), myeloproliferative disorder (blood cancers), pulmonary impairment, asphyxia (a condition of deficient supply of oxygen) and prematurity or underweight in infancy and respiratory symptoms. So, keep your doctor informed about your medical condition and all the medicines you are taking to rule out any side effects.

• Consume a well-balanced and healthy food to aid in your recovery.
• Avoid eating processed food or frozen food. 
• Consume antioxidant-rich foods such as berries, spinach, kidney beans, dark chocolate, and so on.
• Flavonoid-rich foods aid in the reduction of inflammation. Soy, berries, broccoli, grapes, and green tea are examples.
• Limit or quit the consumption of alcohol.
• Quit smoking.